<?xml version="1.0"?>

<document>
	<title>Activated complement in the sputum from patients with cystic
   fibrosis.</title>

	<author>Schiotz-P-O.</author>
	<author>Sorensen-H.</author>
	<author>Hoiby-M.</author>

	<source>Acta-Pathol-Microbiol-Scand [C]. 1979 Feb. 87C(1). P 1-5.</source>

	<abstract>14 cystic fibrosis (CF) patients chronically infected with mucoid P.
   aeruginosa and presenting multiple precipitins in serum against this
   bacterium (CF + P) and 13 CF patients without P. aeruginosa infection
   (CF-P) had their plasma and sputum sol phase examined for albumin,
   Clq. C3/C3c, C4 and C5 by means of electroimmunoassays. Their sputum
   sol phase was examined also for factor B by
   rocketimmunoelectrophoresis. C3c was demonstrated in the sputum sol
   phase but significantly more frequent (p less than 0.01) among the CF
   + P patients than among the CF-P patients. Factor B was also
   demonstrated in the sputum sol phase, but no significant difference
   in frequency could be demonstrated between the CF + P and the CF-P
   patients. None of the results indicated that a local pulmonary
   production of complement factors took place. Complement activation
   was significantly (p less than 0.01) associated with inflammation
   expressed as increased (formula: see text). The results show the
   importance of complement mediated inflammation in the pathogenesis of
   pulmonary tissue damage in patients with CF and support the concept
   of chronic P. aeruginosa lung infection as an immune complex disease
   in CF patients.</abstract>

	<majorsubject>COMPLEMENT-ACTIVATION</majorsubject>
	<majorsubject>COMPLEMENT</majorsubject>
	<majorsubject>CYSTIC-FIBROSIS: im</majorsubject>
	<majorsubject>SPUTUM: im</majorsubject>

	<minorsubject>ADOLESCENCE</minorsubject>
	<minorsubject>ADULT</minorsubject>
	<minorsubject>ALBUMINS: an</minorsubject>
	<minorsubject>CHILD</minorsubject>
	<minorsubject>CHRONIC-DISEASE</minorsubject>
	<minorsubject>COMPLEMENT-3: an</minorsubject>
	<minorsubject>COMPLEMENT-4: an</minorsubject>
	<minorsubject>COMPLEMENT-5: an</minorsubject>
	<minorsubject>COMPLEMENT: an</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co</minorsubject>
	<minorsubject>FEMALE</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS-TWO-DIMENSIONAL</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PNEUMONIA: et, im</minorsubject>
	<minorsubject>PSEUDOMONAS-INFECTIONS: et, im</minorsubject>
	<minorsubject>SERUM-ALBUMIN: an</minorsubject>

	<reference>001   BROGAN TD             THORAX                          30    72 975</reference>
	<reference>002   DIEM K                DOCUMENTA GEIGY SCIENTIFIC TA            962</reference>
	<reference>003   GEWURTZ H             J EXP MED                      128  1049 968</reference>
	<reference>004   GIBSON LE             PEDIATRICS                      23   545 959</reference>
	<reference>005   GREENBLATT J          INFECT IMMUN                    19   296 978</reference>
	<reference>006   HOFF GE               ACTA PATH MICROBIOL SCAND (B)   83   219 975</reference>
	<reference>007   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   541 974</reference>
	<reference>008   HOIBY N               ACTA PATH MICROBIOL SCAND (B)   82   551 974</reference>
	<reference>009   HOIBY N               SCAND J RESPIR DIS              58    65 977</reference>
	<reference>010   LAURELL CB            SCAND J CLIN LAB INVEST SUPPL  124    21 972</reference>
	<reference>011   NELSON RA JR          IN: ZWEIFACH BW                  3    37 974</reference>
	<reference>012   REYNOLDS HY           J LAB CLIN MED                  84   559 974</reference>
	<reference>013   ROBERTSON J           J IMMUNOL                      117   900 976</reference>
	<reference>014   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   83   469 975</reference>
	<reference>015   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   85    57 977</reference>
	<reference>016   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   86    37 978</reference>
	<reference>017   STALENHEIM G          IMMUNOCHEMISTRY                 10   501 973</reference>
	<reference>018   TEISBERG P            CLIN CHIM ACTA                  62    35 975</reference>
	<reference>019   THUESEN-PEDERSEN J    DAN MED BULL                    21    12 974</reference>

	<citation>1   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   87   229 979</citation>
	<citation>2   ETIEVANT M            ANN IMMUNOL (PARIS)           D131    13 980</citation>
	<citation>3   SKOV PS               ALLERGY                         35    23 980</citation>
	<citation>4   SCHIOTZ PO            ACTA PATH MICROBIOL SCAND (C)   88   275 980</citation>
	<citation>5   SMITH TF              INFECT IMMUN                    33    43 981</citation>
	<citation>6   MOSS RB               CLIN EXP IMMUNOL                47   301 982</citation>
	<citation>7   BECK B                ACTA PAEDIATR SCAND SUPPL 301 1982   125 982</citation>
	<citation>8   HOIBY N               ACTA PAEDIATR SCAND SUPPL 301 1982    63 982</citation>
	<citation>9   SCHIOTZ PO            ACTA PAEDIATR SCAND SUPPL 301 1982    55 982</citation>
	<citation>10   SCHIOTZ PO            ACTA PAEDIATR SCAND             72   283 983</citation>
	<citation>11   PIER GB               J INFECT DIS                   150   223 984</citation>
	<citation>12   SORDELLI DO           EUR J RESPIR DIS                67   118 985</citation>
	<citation>13   GOTZ M                MONATSSCHR KINDERHEILKD        133   718 985</citation>
	<citation>14   KHARAZMI A            EUR J CLIN INVEST               16   143 986</citation>
	<citation>15   HOIBY N               ANNU REV MICROBIOL              40    29 986</citation>
	<citation>16   EDWARDS KM            ARCH VIROL                      88    49 986</citation>
	<citation>17   MOSS RB               AM REV RESPIR DIS              133   648 986</citation>

</document>
